Stockscreener 앱 받기
69.90
1.20%
-0.85
시간 외 거래:
69.90
전일 마감가:
$70.75
열려 있는:
$70.51
하루 거래량:
310.48K
Relative Volume:
0.89
시가총액:
$2.43B
수익:
-
순이익/손실:
$-91.00M
주가수익비율:
-19.05
EPS:
-3.67
순현금흐름:
$-74.38M
1주 성능:
+3.13%
1개월 성능:
+16.62%
6개월 성능:
+98.41%
1년 성능:
+47.25%
1일 변동 폭
$68.82
$70.89
1주일 범위
$67.22
$72.68
52주 변동 폭
$30.82
$72.68
Disc Medicine Inc Stock (IRON) Company Profile
명칭
Disc Medicine Inc
전화
(617) 674-9274
주소
321 ARSENAL STREET, SUITE 101, WATERTOWN
IRON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
69.90 | 2.46B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-06-11 | 재개 | Raymond James | Strong Buy |
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 개시 | H.C. Wainwright | Buy |
| 2023-05-17 | 개시 | Raymond James | Outperform |
| 2023-04-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 개시 | Stifel | Buy |
| 2023-04-20 | 개시 | Morgan Stanley | Overweight |
| 2023-03-23 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-28 | 개시 | SVB Securities | Outperform |
모두보기
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Price action breakdown for Disc Medicine Inc.Weekly Stock Summary & High Accuracy Investment Entry Signals - newser.com
Tick level data insight on Disc Medicine Inc. volatilityPortfolio Value Summary & Daily Entry Point Alerts - newser.com
Real time social sentiment graph for Disc Medicine Inc.July 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Disc Medicine's (IRON) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Bitterman Kevin, director at Disc Medicine, sells $6.3m in shares - Investing.com India
Building trade automation scripts for Disc Medicine Inc.July 2025 PreEarnings & Verified Swing Trading Watchlists - newser.com
Using RSI to spot recovery in Disc Medicine Inc.Quarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
Visual trend scoring systems applied to Disc Medicine Inc.2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
Momentum divergence signals in Disc Medicine Inc. chartTrade Analysis Summary & Reliable Price Breakout Alerts - newser.com
Real time pattern detection on Disc Medicine Inc. stockDip Buying & Reliable Entry Point Alerts - newser.com
Quantitative breakdown of Disc Medicine Inc. recent moveQuarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com
Disc Medicine (NASDAQ:IRON) Sets New 52-Week HighTime to Buy? - MarketBeat
Disc Medicine stock hits 52-week high at 69.38 USD By Investing.com - Investing.com Nigeria
Disc Medicine director Mona Ashiya resigns, board size reduced to eight - Investing.com
Disc Medicine Board Member Mona Ashiya Resigns - TipRanks
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Disc Medicine stock hits 52-week high at 69.38 USD - Investing.com
Identifying reversal signals in Disc Medicine Inc.Market Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Is Disc Medicine Inc. stock cheap at current valuationPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Developing predictive dashboards with Disc Medicine Inc. data2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Is Disc Medicine Inc. showing signs of accumulation2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is a relief rally coming for Disc Medicine Inc. holdersEarnings Miss & Stock Portfolio Risk Management - newser.com
What momentum shifts mean for Disc Medicine Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Will Disc Medicine Inc. stock recover after recent dropEarnings Growth Summary & Daily Technical Forecast Reports - newser.com
Should you wait for a breakout in Disc Medicine Inc.2025 Market Outlook & Expert Curated Trade Setups - newser.com
Analyzing Disc Medicine Inc. with risk reward ratio charts2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
A Fresh Look at Disc Medicine’s Valuation After Bitopertin NDA Submission and Positive Phase 2 Data - Yahoo Finance
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP) - Sahm
Disc MedicineBiotech Stock On The Move With Multiple Near-Term Catalysts - RTTNews
Disc Medicine (NASDAQ:IRON) Sets New 1-Year HighHere's Why - MarketBeat
Disc Medicine submits NDA for bitopertin in erythropoietic porphyria By Investing.com - Investing.com Nigeria
Disc Medicine Announces Submission of New Drug Application - GlobeNewswire
Disc Medicine Announces Submission Of NDA For Bitopertin - Nasdaq
Disc Medicine Submits New Drug Application to FDA for Bitopertin to Treat Patients With Erythropoietic Protoporphyria - MarketScreener
Disc Medicine submits NDA for bitopertin in erythropoietic porphyria - Investing.com
Disc Medicine Inc (IRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Disc Medicine Inc 주식 (IRON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bitterman Kevin | Director |
Oct 07 '25 |
Sale |
68.38 |
18,039 |
1,233,493 |
572,582 |
5.74%
자본화:
|
볼륨(24시간):